BDSX vs XGN
Biodesix, Inc. - Common Stock · Exagen Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | BDSX | XGN |
|---|---|---|
| Price | $27.96 | $8.19 |
| Market Cap | $295.01M | $198.41M |
| P/E | — | — |
| P/B | 32.26 | 16.24 |
| P/S | 3.33 | 2.98 |
| ROE | -385.7% | -163.3% |
| Net Margin | -39.8% | -30.0% |
| Gross Margin | — | 58.3% |
| Revenue Growth | 24.1% | 19.7% |
| Dividend Yield | — | — |
| EPS | -$3.34 | -$0.82 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.